Delivery Order SPE2DB20D2002-SPE2DB24FL13B
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Janumet 50-1,000 mg tablets. The $3,687.54 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products...
- This federal contract award, valued at $13,576.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Janumet 50-1,000 mg tablets in quantities of 180 per bottle. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 29, 2024. The contract was awarded on a full and open competition basis without any set-aside designations. Amerisourcebergen Drug Corp is a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,212.44 for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,635.58 for the supply of JANUMET 50-1,000 MG TABLET 180S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 27, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $7,466.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with an ultimate completion date of January 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Janumet 50-1,000 mg tablets (180 count) to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The $4,852.16 firm-fixed-price delivery order was awarded on September 30, 2022, with an ultimate completion date of October 3, 2022. The contract does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, leverages its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,415.62, is for the delivery of Janumet 50-1,000 mg tablets. The award is a Firm Fixed Price Delivery Order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $36,595.16 Firm Fixed Price Delivery Order is for the supply of Janumet 50-1,000 mg tablets. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for JANUMET 50-1,000 mg tablets. The $3,721.03 firm fixed price delivery order has a completion date of December 4, 2024. The contract is not designated as a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The $3,316.70 firm fixed-price delivery order, which has an ultimate completion date of March 28, 2022, is for the provision of JANUMET 50-500 MG TABLET 180S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB24FL13BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Janumet 50-1,000 mg tablets. The $4,480.20 firm fixed-price delivery order has a completion date of December 29, 2023 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs serve as primary vehicles for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and various medical devices and equipment, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 12/28/23 |